Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
178,446,454
-
Share change
-
+114,692,115
-
Total reported value
-
$3,633,871,563
-
Put/Call ratio
-
104%
-
Price per share
-
$20.37
-
Number of holders
-
365
-
Value change
-
+$2,339,014,740
-
Number of buys
-
329
-
Number of sells
-
21
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2019
As of 31 Mar 2019 TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) had 365 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 178,446,454 shares of stock of the company.
Largest 10 holders included GLENVIEW CAPITAL MANAGEMENT, LLC, PAULSON & CO. INC., BAUPOST GROUP LLC/MA, Adelphi Capital LLP, FMR LLC, VANGUARD GROUP INC, TIAA CREF INVESTMENT MANAGEMENT LLC, Sachem Head Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, and MACQUARIE GROUP LTD.
This table shows 365 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.